An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries

Abstract Background The Canadian government has committed to developing a national strategy for drugs for rare diseases starting in 2022. Considering this announcement, we conducted a comparative analysis to examine patient access to therapies for rare disease in Canada relative to Europe and the U....

Full description

Bibliographic Details
Main Authors: Ward, Leanne Marie, Chambers, Alexandra, Mechichi, Emine, Wong-Rieger, Durhane, Campbell, Craig
Format: Article in Journal/Newspaper
Language:unknown
Published: figshare 2022
Subjects:
Online Access:https://dx.doi.org/10.6084/m9.figshare.c.5877425
https://springernature.figshare.com/collections/An_international_comparative_analysis_of_public_reimbursement_of_orphan_drugs_in_Canadian_provinces_compared_to_European_countries/5877425